Perform clinical stage drug discovery and developing next generation protein and cell-based therapeutics.
Data last updated:May 8, 2024 – 3.49pm. Data is 20 mins delayed.
Previous Close | 0.024 |
|---|---|
Open | 0.022 |
Day Range | 0.022 - 0.026 |
52 Week Range | 0.017 - 0.048 |
Volume | 2,273,731 |
Value | 53,008 |
Bid | 0.023 |
|---|---|
Ask | 0.026 |
Dividend Yield | 0.00% |
P/E Ratio | 0.00 |
Market Cap | 13.848M |
Total Issue | 532,624,077 |
Application for quotation of securities - 1AD
Appendix 2A (Application for Quotation of Securities)
Application for quotation of securities - 1AD
Appendix 2A (Application for Quotation of Securities)
Application for quotation of securities - 1AD
Appendix 2A (Application for Quotation of Securities)
No stories for AdAlta Limited are available.
Search afr.com for AdAlta Limited storiesCopyright © 2024. Company information displayed on The Australian Financial Review is sourced from Morningstar and ASX and is subject to their terms and conditions as set out in our Terms of Use. The Australian Financial Review does not accept any responsibility for the accuracy and/or completeness of such data or information.
Sponsored
by Sydney Children’s Hospitals Foundation
Sponsored
by Future Fund
Sponsored
by AGL Energy
